Aortic Valve
This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with Dr. Chris Malaisrie, a Professor of Surgery in the Division of Cardiac Surgery at Northwestern University and an Attending Cardiac Surgeon at Northwestern Medicine,...
This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with CTSNet Senior Editor—Global Emily Farkas, Associate Director of Global Health in Surgery at the Indiana University School of Medicine,...
The authors present a 75-year-old woman with dyspnea on exertion. She was diagnosed with an aortic valve stenosis and moderate-to-severe mitral valve regurgitation due to a localized A2 prolapse. This...
This cardiac session features leading surgeon Mario Castillo-Sang presenting on intraoperative pearls and pitfalls at the International Society for Minimally Invasive Cardiothoracic Surgery Annual Scientific Meeting 2026. CTSNet Senior Editor—Cardiac...
This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with Dr. Aamir Amin, a cardiothoracic surgery resident at Manchester University NHS Foundation Trust, UK, about humanoid robots and artificial...
The utility of operating room extubation (ORE) after cardiac surgery over fast-track extubation (FTE) within 6 hours remains contested. The authors hypothesized ORE would be associated with equivalent rates of...
Valve sparing root replacement requires meticulous surgical techniques to restore aortic valve function. Several methods have been used to assess aortic valve competency post reconstruction, including visual inspection, water injection,...
The selection of valve prostheses for patients undergoing surgical aortic valve replacement (SAVR) remains controversial. In this study, the authors compared the long-term outcomes of patients undergoing aortic valve replacement...
The patient is a thirty-year-old woman who underwent an aortic valve replacement in 2021, aortic prosthesis and mitral valve replacement in 2022 for endocarditis, and a redo operation for dysfunction/dehiscence...
This paper reports the interim findings from the clinical registry that was initiated after FDA approval to validate the findings of the 386 PROACT trial for the On-X aortic valve....
The search for an ideal cardiac valve substitute continues. Homografts have the advantages of resistance to infection, superior hemodynamic profile, and avoidance of anticoagulation compared to the conventional prosthetic valves...
In an analysis of 1,826 patients randomized to surgical aortic valve replacement in the three Placement of Aortic Transcatheter Valves (PARTNER) trials, patient-prosthesis mismatch was assessed using transthoracic echocardiography and...
Surgical explantation of transcatheter heart valves (THV) is rapidly increasing, but data on patients with THV-associated infective endocarditis (IE) is lacking. This study assessed the outcomes of patients undergoing THV...






